PTC Therapeutics Inc (STU:BH3)
€ 36.8 0 (0%) Market Cap: 2.89 Bil Enterprise Value: 2.25 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

PTC Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 02:10PM GMT
Release Date Price: €48.4 (-3.20%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Good morning, everyone. My name is Gena Wang. I'm Biotech Analyst at the Barclays. Welcome to our Second Virtual Global Healthcare Conference. First, I wish everyone stay healthy, and I would like to thank all the participants, investors, companies and especially our event team, our corporate access team, who made this Virtual Healthcare Conference possible.

With that, I would like to introduce our next presenting company PTC Therapeutics. With us today, we have Matthew Klein, Chief Development Officer; and also Kylie O'Keefe, Head of Global Strategic Marketing and Business Intelligence. With that, I hand over to you, Matt.

Matthew B. Klein
PTC Therapeutics, Inc. - Chief Development Officer

Great. Thank you very much, Gena. It's a pleasure to be here today and being able to share a lot of exciting updates from us here at PTC. Let me just get into slide show mode.

Great. Today, I will be making forward-looking statements. I refer everyone to our SEC filings. For those of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot